Bladder cancer
Conditions
Interventions
BCG therapy:None
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
20 Years to 95 Years
Inclusion criteria
Inclusion criteria: ??Inclusion Criteria (All Must Be Met)??: 1.Diagnosed with ??non-muscle-invasive bladder cancer (NMIBC)?? after ??transurethral resection of bladder tumor (TURBT)??. 2.Received ??intravesical therapy?? (BCG or chemotherapy drugs) after TURBT, with ??at least 3 instillations?? completed. 3.Pathological type is ??urothelial carcinoma??.
Exclusion criteria
Exclusion criteria: Exclusion Criteria (Any of the Following)??: 1.Post-TURBT pathology confirmed ??non-NMIBC?? (e.g., muscle-invasive bladder cancer, prostate cancer, metastatic cancer, etc.). 2.Pathological type is ??mixed??, with ??non-urothelial carcinoma?? as the predominant component. 3.History of ??immunodeficiency diseases?? (e.g., acquired immunodeficiency, systemic lupus erythematosus). ??4.Incomplete medical records??, lacking essential information for outcome evaluation. 5.??Incomplete instillation records?, including instillation time, drug name, dosage, or administration details.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence-Free Survival (RFS); | — |
Countries
China
Contacts
Public ContactHan Ping
West China Hospital, Sichuan University
Outcome results
None listed